Unlocking the health benefits of cannabinoids.

We are a team of medical experts.

Medical Advisory Board

Our Medical Advisory Board is made up of renowned Healthcare Professionals whose unique perspectives and expertise inform the strategic direction and success of the company.

Political Advisory Board

Our Political Advisory Board comprises renowned political experts and healthcare professionals who provide strategic guidance and advice to support Sanity Group to meet its mission and objectives.

Latest News

Sanity Group Secures Additional Growth Capital Amounting to a Total of 17 Million Euros

Sanity Group GmbH, one of Germany’s leading cannabis companies, announced the completion of an investment from the Jupiter Fund of Organigram Holdings Inc., a leading licensed cannabis producer based in Toronto, Canada, today. This marks Organigram’s first investment in the European cannabis market. Using funds from the Jupiter Fund, the Canadian producer is investing 14 million euros in the form of a convertible loan into Sanity Group. Additionally, the company has the option to call for a second tranche of three million euros as part of the convertible loan. Simultaneously with the investment, Organigram and Sanity Group have agreed on a new supply agreement to deepen their partnership, which has been in place since 2023.

Read more

Federal Council: Cannabis Legalization to Take Effect on April 1st

With the passage through the Federal Council, the planned partial legalization of cannabis in Germany has successfully cleared the final parliamentary hurdle today: The Cannabis Act “CanG” (Pillar 1) officially comes into effect on April 1st, as the convocation of the compromise committee did not materialize. In today’s vote, a minority advocated for a compromise committee, while the majority abstained or voted against. For the German cannabis industry, this marks an important, albeit only initial step, states Finn Hänsel, founder and CEO of the Berlin-based cannabis company Sanity Group: “The foundation for the decriminalization and destigmatization of consumers, but above all, for better patient care with medicinal cannabis, has been laid today. Now the real work begins.” A timely implementation of the second pillar of CanG is now essential. In the medical context, due to the removal of cannabis from the Narcotics Act, a significant increase in the number of patients is expected, as access to this form of therapy is significantly simplified.

Read more

Europe’s first legal cannabis specialist store has opened: “Grashaus Projects” in Switzerland officially launched

Press release –– In a historic step, Switzerland and Europe are breaking new ground: this week, the first legal cannabis store in Europe officially opened its doors in the municipality of Allschwil in the north-western Swiss canton of Basel-Landschaft. To mark the start of the Grashaus Projects pilot project for the controlled distribution of cannabis for recreational purposes, study participants in Basel-Landschaft can now purchase various THC-containing cannabis products – from flowers to hashish, extracts, vape liquids and edibles – at the store under the guidance of trained specialist staff. It is the first store of its kind on the European continent.

Read more